Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain zaps may boost movement in kids with cerebral palsy

NCT ID NCT07567053

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a non-invasive brain stimulation technique called rTMS to improve motor function in 60 children with cerebral palsy. The treatment uses magnetic pulses to enhance brain plasticity and movement recovery. Researchers will measure brain activity changes to see if this approach can speed up rehabilitation and reduce long-term healthcare needs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 20 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (CP): * Aged 6 - 20 years, * A confirmed diagnosis of CP by a specialized professional (pediatric neurologist, PM\&R physician, neonatal developmental specialist, or neonatologist) is a prerequisite for participation, * Classified as high functioning (Level I, II, or III) according to the Gross Motor Function Classification System (GMFCS), * Age-appropriate ability to understand and comply with study procedure throughout the entire duration of the study, * Preserved vision and hearing (with or without correction). Inclusion Criteria (TD): * Aged 6 - 20 years * Age-appropriate ability to understand and comply with study procedure throughout the entire duration of the study, * Preserved vision and hearing (with or without correction). Exclusion Criteria (CP): * Syndromic or genetic brain-related associations, * History of major trauma or brain surgery, * Inability to remain still, * History of Epilepsy, * Severe coexisting sickness or illness unrelated to CP or unstable medical conditions such as pneumonia, * Modified Ashworth Scale: Shoulder, elbow, and wrist scores more than 3, * Limb contractures caused by any other injury except CP, * Severe movement disorders that prevent intentional limb movements, such as choreoathetosis, or ballismus, * Contraindications for rTMS include non-removable metallic objects close to a coil and implanted electronic devices, such as cochlear implants and pacemakers. Exclusion Criteria (TD): * Syndromic or genetic brain-related associations, * History of major trauma or brain surgery, * Inability to remain still, * History of Epilepsy, * Severe coexisting sickness or illness unrelated to CP or unstable medical conditions such as pneumonia, * Limb contractures caused by injury, * Severe movement disorders that prevent intentional limb movements, such as choreoathetosis, or ballismus, * Contraindications for rTMS include non-removable metallic objects close to a coil and implanted electronic devices, such as cochlear implants and pacemakers.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cook Children's Hospital

    Fort Worth, Texas, 76107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.